[1]
“Tissue plasminogen activator (tPA) treatment for COVID 19 associated respiratory failure: A case Series”, Bangladesh Crit Care J, vol. 10, no. 1, pp. 62–67, Apr. 2022, doi: 10.3329/bccj.v10i1.59207.